CIRCULATING ANTIOVARIAN ANTIBODIES IN PREMATURE OVARIAN FAILURE
- 1 December 1986
- journal article
- research article
- Vol. 68 (6) , 850-854
Abstract
The presence of antiovarian antibodies in sera of women with premature ovarian failure was determined by an indirect fluorescent antibody assay using human ovarian tissue. Of 27 patients, 14 had positive ovarian fluorescence, compared with zero of 24 normal cycling controls (P < .001) and one of 22 postmenopausal controls (P < .01). In patients with autoimmune disease, five of 17 demonstrated positive fluorescence compared with zero of 24 premenopausal controls (P < .01). Immunoperoxidase staining revealed antigen concentrated at the granulosa cells and oocyte in nine of the 14 ovarian failure cases. The finding that a significant proportion of patients with premature ovarian failure have circulating antiovarian antibodies confirms previous studies, but localization of peroxidase staining to granulosa cells and/or oocytes respresents a new finding in this study.This publication has 7 references indexed in Scilit:
- Immunization with Zona Pellucida Proteins Results in Abnormal Ovarian Follicular Differentiation and Inhibition of Gonadotropin-Induced Steroid Secretion*Endocrinology, 1984
- Premature ovarian failure: A search for circulating factors against gonadotropin receptorsAmerican Journal of Obstetrics and Gynecology, 1983
- The incidence of anti-zona activity in post-menopausal womenMaturitas, 1982
- Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: suggestion of similar autoimmune mechanismsActa Endocrinologica, 1982
- Myasthenia gravis and premature ovarian failureArchives of internal medicine (1960), 1981
- Premature menopauseAmerican Journal of Obstetrics and Gynecology, 1979
- Radioimmunoassay for Human Luteinizing Hormone.Experimental Biology and Medicine, 1967